Pharma & Healthcare
Global Meningococcal Group B Vaccine Market Research Report 2025
- Sep 09, 25
- ID: 497263
- Pages: 70
- Figures: 70
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Meningococcal Group B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Group B Vaccine.
The Meningococcal Group B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meningococcal Group B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Group B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
Pfizer
Segment by Type
Bexsero
Trumenba
Other
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningococcal Group B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningococcal Group B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Meningococcal Group B Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Group B Vaccine.
The Meningococcal Group B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meningococcal Group B Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meningococcal Group B Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
Pfizer
Segment by Type
Bexsero
Trumenba
Other
Segment by Application
Public
Private
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meningococcal Group B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meningococcal Group B Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Meningococcal Group B Vaccine Market Overview
1.1 Product Definition
1.2 Meningococcal Group B Vaccine by Type
1.2.1 Global Meningococcal Group B Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bexsero
1.2.3 Trumenba
1.2.4 Other
1.3 Meningococcal Group B Vaccine by Application
1.3.1 Global Meningococcal Group B Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Meningococcal Group B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Group B Vaccine Revenue 2020-2031
1.4.2 Global Meningococcal Group B Vaccine Sales 2020-2031
1.4.3 Global Meningococcal Group B Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meningococcal Group B Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meningococcal Group B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningococcal Group B Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningococcal Group B Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Meningococcal Group B Vaccine, Date of Enter into This Industry
2.8 Global Meningococcal Group B Vaccine Market Competitive Situation and Trends
2.8.1 Global Meningococcal Group B Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
2.8.3 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meningococcal Group B Vaccine Market Scenario by Region
3.1 Global Meningococcal Group B Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meningococcal Group B Vaccine Sales by Region: 2020-2031
3.2.1 Global Meningococcal Group B Vaccine Sales by Region: 2020-2025
3.2.2 Global Meningococcal Group B Vaccine Sales by Region: 2026-2031
3.3 Global Meningococcal Group B Vaccine Revenue by Region: 2020-2031
3.3.1 Global Meningococcal Group B Vaccine Revenue by Region: 2020-2025
3.3.2 Global Meningococcal Group B Vaccine Revenue by Region: 2026-2031
3.4 North America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.4.1 North America Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.4.3 North America Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.5.3 Europe Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Meningococcal Group B Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meningococcal Group B Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningococcal Group B Vaccine Sales by Type (2020-2031)
4.1.1 Global Meningococcal Group B Vaccine Sales by Type (2020-2025)
4.1.2 Global Meningococcal Group B Vaccine Sales by Type (2026-2031)
4.1.3 Global Meningococcal Group B Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Meningococcal Group B Vaccine Revenue by Type (2020-2031)
4.2.1 Global Meningococcal Group B Vaccine Revenue by Type (2020-2025)
4.2.2 Global Meningococcal Group B Vaccine Revenue by Type (2026-2031)
4.2.3 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Meningococcal Group B Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meningococcal Group B Vaccine Sales by Application (2020-2031)
5.1.1 Global Meningococcal Group B Vaccine Sales by Application (2020-2025)
5.1.2 Global Meningococcal Group B Vaccine Sales by Application (2026-2031)
5.1.3 Global Meningococcal Group B Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Meningococcal Group B Vaccine Revenue by Application (2020-2031)
5.2.1 Global Meningococcal Group B Vaccine Revenue by Application (2020-2025)
5.2.2 Global Meningococcal Group B Vaccine Revenue by Application (2026-2031)
5.2.3 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Meningococcal Group B Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Meningococcal Group B Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Meningococcal Group B Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningococcal Group B Vaccine Industry Chain Analysis
7.2 Meningococcal Group B Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningococcal Group B Vaccine Production Mode & Process Analysis
7.4 Meningococcal Group B Vaccine Sales and Marketing
7.4.1 Meningococcal Group B Vaccine Sales Channels
7.4.2 Meningococcal Group B Vaccine Distributors
7.5 Meningococcal Group B Vaccine Customer Analysis
8 Meningococcal Group B Vaccine Market Dynamics
8.1 Meningococcal Group B Vaccine Industry Trends
8.2 Meningococcal Group B Vaccine Market Drivers
8.3 Meningococcal Group B Vaccine Market Challenges
8.4 Meningococcal Group B Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Meningococcal Group B Vaccine by Type
1.2.1 Global Meningococcal Group B Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bexsero
1.2.3 Trumenba
1.2.4 Other
1.3 Meningococcal Group B Vaccine by Application
1.3.1 Global Meningococcal Group B Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Public
1.3.3 Private
1.4 Global Meningococcal Group B Vaccine Market Size Estimates and Forecasts
1.4.1 Global Meningococcal Group B Vaccine Revenue 2020-2031
1.4.2 Global Meningococcal Group B Vaccine Sales 2020-2031
1.4.3 Global Meningococcal Group B Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meningococcal Group B Vaccine Market Competition by Manufacturers
2.1 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meningococcal Group B Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meningococcal Group B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meningococcal Group B Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meningococcal Group B Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Meningococcal Group B Vaccine, Date of Enter into This Industry
2.8 Global Meningococcal Group B Vaccine Market Competitive Situation and Trends
2.8.1 Global Meningococcal Group B Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue
2.8.3 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meningococcal Group B Vaccine Market Scenario by Region
3.1 Global Meningococcal Group B Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meningococcal Group B Vaccine Sales by Region: 2020-2031
3.2.1 Global Meningococcal Group B Vaccine Sales by Region: 2020-2025
3.2.2 Global Meningococcal Group B Vaccine Sales by Region: 2026-2031
3.3 Global Meningococcal Group B Vaccine Revenue by Region: 2020-2031
3.3.1 Global Meningococcal Group B Vaccine Revenue by Region: 2020-2025
3.3.2 Global Meningococcal Group B Vaccine Revenue by Region: 2026-2031
3.4 North America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.4.1 North America Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.4.3 North America Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country
3.5.1 Europe Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.5.3 Europe Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Meningococcal Group B Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meningococcal Group B Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country
3.7.1 Latin America Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Meningococcal Group B Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meningococcal Group B Vaccine Sales by Type (2020-2031)
4.1.1 Global Meningococcal Group B Vaccine Sales by Type (2020-2025)
4.1.2 Global Meningococcal Group B Vaccine Sales by Type (2026-2031)
4.1.3 Global Meningococcal Group B Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Meningococcal Group B Vaccine Revenue by Type (2020-2031)
4.2.1 Global Meningococcal Group B Vaccine Revenue by Type (2020-2025)
4.2.2 Global Meningococcal Group B Vaccine Revenue by Type (2026-2031)
4.2.3 Global Meningococcal Group B Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Meningococcal Group B Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meningococcal Group B Vaccine Sales by Application (2020-2031)
5.1.1 Global Meningococcal Group B Vaccine Sales by Application (2020-2025)
5.1.2 Global Meningococcal Group B Vaccine Sales by Application (2026-2031)
5.1.3 Global Meningococcal Group B Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Meningococcal Group B Vaccine Revenue by Application (2020-2031)
5.2.1 Global Meningococcal Group B Vaccine Revenue by Application (2020-2025)
5.2.2 Global Meningococcal Group B Vaccine Revenue by Application (2026-2031)
5.2.3 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Meningococcal Group B Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Meningococcal Group B Vaccine Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Meningococcal Group B Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meningococcal Group B Vaccine Industry Chain Analysis
7.2 Meningococcal Group B Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meningococcal Group B Vaccine Production Mode & Process Analysis
7.4 Meningococcal Group B Vaccine Sales and Marketing
7.4.1 Meningococcal Group B Vaccine Sales Channels
7.4.2 Meningococcal Group B Vaccine Distributors
7.5 Meningococcal Group B Vaccine Customer Analysis
8 Meningococcal Group B Vaccine Market Dynamics
8.1 Meningococcal Group B Vaccine Industry Trends
8.2 Meningococcal Group B Vaccine Market Drivers
8.3 Meningococcal Group B Vaccine Market Challenges
8.4 Meningococcal Group B Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Meningococcal Group B Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Meningococcal Group B Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Meningococcal Group B Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Meningococcal Group B Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Meningococcal Group B Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Meningococcal Group B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meningococcal Group B Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meningococcal Group B Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Meningococcal Group B Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meningococcal Group B Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Meningococcal Group B Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Meningococcal Group B Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Meningococcal Group B Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Meningococcal Group B Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Meningococcal Group B Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Meningococcal Group B Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Meningococcal Group B Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Meningococcal Group B Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Meningococcal Group B Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Meningococcal Group B Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Meningococcal Group B Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Meningococcal Group B Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Meningococcal Group B Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Meningococcal Group B Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Meningococcal Group B Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. GSK Meningococcal Group B Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Meningococcal Group B Vaccine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Meningococcal Group B Vaccine Distributors List
Table 83. Meningococcal Group B Vaccine Customers List
Table 84. Meningococcal Group B Vaccine Market Trends
Table 85. Meningococcal Group B Vaccine Market Drivers
Table 86. Meningococcal Group B Vaccine Market Challenges
Table 87. Meningococcal Group B Vaccine Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Meningococcal Group B Vaccine
Figure 2. Global Meningococcal Group B Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Meningococcal Group B Vaccine Market Share by Type: 2024 & 2031
Figure 4. Bexsero Product Picture
Figure 5. Trumenba Product Picture
Figure 6. Other Product Picture
Figure 7. Global Meningococcal Group B Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Meningococcal Group B Vaccine Market Share by Application: 2024 & 2031
Figure 9. Public
Figure 10. Private
Figure 11. Global Meningococcal Group B Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Meningococcal Group B Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Meningococcal Group B Vaccine Sales (2020-2031) & (K Units)
Figure 14. Global Meningococcal Group B Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 15. Meningococcal Group B Vaccine Report Years Considered
Figure 16. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Meningococcal Group B Vaccine Players: Market Share by Revenue in Meningococcal Group B Vaccine in 2024
Figure 19. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Meningococcal Group B Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. the United States Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Meningococcal Group B Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Meningococcal Group B Vaccine by Type (2020-2031)
Figure 55. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Meningococcal Group B Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Meningococcal Group B Vaccine by Application (2020-2031)
Figure 58. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 59. Meningococcal Group B Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Meningococcal Group B Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Meningococcal Group B Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Meningococcal Group B Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Meningococcal Group B Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Meningococcal Group B Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Meningococcal Group B Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Meningococcal Group B Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Meningococcal Group B Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Meningococcal Group B Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Group B Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Meningococcal Group B Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Meningococcal Group B Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Meningococcal Group B Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Meningococcal Group B Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Meningococcal Group B Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Meningococcal Group B Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Meningococcal Group B Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Meningococcal Group B Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Meningococcal Group B Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Meningococcal Group B Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Meningococcal Group B Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Meningococcal Group B Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2020-2025)
Table 59. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2026-2031)
Table 60. Global Meningococcal Group B Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Meningococcal Group B Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Meningococcal Group B Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Meningococcal Group B Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Meningococcal Group B Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2020-2025)
Table 69. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. GSK Meningococcal Group B Vaccine Product
Table 74. GSK Recent Developments/Updates
Table 75. Pfizer Company Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Pfizer Meningococcal Group B Vaccine Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Key Raw Materials Lists
Table 81. Raw Materials Key Suppliers Lists
Table 82. Meningococcal Group B Vaccine Distributors List
Table 83. Meningococcal Group B Vaccine Customers List
Table 84. Meningococcal Group B Vaccine Market Trends
Table 85. Meningococcal Group B Vaccine Market Drivers
Table 86. Meningococcal Group B Vaccine Market Challenges
Table 87. Meningococcal Group B Vaccine Market Restraints
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
Table 91. Authors List of This Report
List of Figures
Figure 1. Product Picture of Meningococcal Group B Vaccine
Figure 2. Global Meningococcal Group B Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Meningococcal Group B Vaccine Market Share by Type: 2024 & 2031
Figure 4. Bexsero Product Picture
Figure 5. Trumenba Product Picture
Figure 6. Other Product Picture
Figure 7. Global Meningococcal Group B Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Meningococcal Group B Vaccine Market Share by Application: 2024 & 2031
Figure 9. Public
Figure 10. Private
Figure 11. Global Meningococcal Group B Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Meningococcal Group B Vaccine Market Size (2020-2031) & (US$ Million)
Figure 13. Global Meningococcal Group B Vaccine Sales (2020-2031) & (K Units)
Figure 14. Global Meningococcal Group B Vaccine Average Price (USD/Unit) & (2020-2031)
Figure 15. Meningococcal Group B Vaccine Report Years Considered
Figure 16. Meningococcal Group B Vaccine Sales Share by Manufacturers in 2024
Figure 17. Global Meningococcal Group B Vaccine Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Meningococcal Group B Vaccine Players: Market Share by Revenue in Meningococcal Group B Vaccine in 2024
Figure 19. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Meningococcal Group B Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 22. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 23. the United States Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 26. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 27. Germany Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. UK Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2020-2031)
Figure 34. China Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Meningococcal Group B Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Meningococcal Group B Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Meningococcal Group B Vaccine by Type (2020-2031)
Figure 55. Global Meningococcal Group B Vaccine Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Meningococcal Group B Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Meningococcal Group B Vaccine by Application (2020-2031)
Figure 58. Global Meningococcal Group B Vaccine Price (USD/Unit) by Application (2020-2031)
Figure 59. Meningococcal Group B Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232